Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease ...

We recently published a list of the 12 Stocks to Buy That May Be Splitting Soon. In this article, we are going to take a look ...

Eli Lilly (LLY) closed the latest trading day at $822.51, indicating a -0.27% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 1.07%. On the ...

Eli Lilly (NYSE:LLY) has recently unveiled significant advancements across its product line, including promising results from ...

Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on ...

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ...

and help to win market share. In an unrelated announcement, Lilly said it has cut the price for 2.5-milligram and 5-mg vial doses of its Zepbound (tirzepatide) GLP-1 weight loss drug. Lilly also ...

The reductions come at a time of significant growth overall for Lilly. and soon after the announcement of plans to build new ...

While it has the potential to gain market share against NVO, Lilly management also highlighted ... I believe its price action has demonstrated higher conviction that the stock is ready to go ...